Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer
Trial Parameters
Brief Summary
PREDAtOOR is a pilot study and this study aims at improving the selection of the best treatment strategy for patients with advanced ovarian cancer by using Camera Vision (CV) to predict outcomes of cyto reduction at the time of Diagnostic laparoscopy.
Eligibility Criteria
Inclusion Criteria: * Patients treated at Fondazione Policlinico Gemelli Hospital, Rome Italy, Trillium -Credit Valley Hospital, Mississauga, Ontario and Princess Margaret Cancer Centre, Toronto, Canada * Patients fit for cytoreductive surgery * Patients with a primary diagnosis of suspect Stage III-IV ovarian cancer * Patients selected for interval cytoreductive surgery after NACT Exclusion Criteria: * Patients with pre-operative Stage I-II disease confined to the pelvis * Patients unfit for surgery * Lack of information about patients' surgical outcomes and clinicopathological characteristics * LGSOC, Clear cell and mucinous, non-epithelial histologic subtypes (if available)